Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02628 CHINA LIFE
RTNominal down18.480 -0.100 (-0.538%)
Others

06/12/2019 09:34

{I-bank focus}Morgan raises China Life (02628) to HK$23

[ET Net News Agency, 6 December 2019] Morgan Stanley raised its target price for China
Life Insurance (02628) to HK$23 from HK$22 and maintained its "equal-weight" rating.
The research house said China Life's share price performed strongly in 2019, with its
H-shares up 20% year-to-date versus 6% on average for the industry (H-share insurers) on a
substantial growth recovery - the company is on track to report >15% VNB (value of new
business) growth and >400% earnings growth for 2019, one of the highest amongst listed
peers, partially due to a low base in 2018.
Management is guiding for continued double-digit VNB growth for 2020, driven by
continued margin improvement and sales force expansion. If achieved, this could further
lift market confidence in its execution and lead to further rerating in 2020. (KL)

Remark: Real time quote last updated: 26/02/2020 15:35
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2020 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.